Latest Breaking News On - Foreign issuer - Page 1 : comparemela.com

AstraZeneca : plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore - Form 6-K

A0072p FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

Gilat Satellite : David McDonald will transition to the role of Vice Chairman of DataPath Board of Directors - Form 6-K

FORM 6 - K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K

A6269o FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K

Notice of Annual General Meeting